Related Experiment Video
Updated: Jan 20, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
[Advances in research on the role of alveolar macrophage burial function in chronic obstructive pulmonary disease]
Xuening Liu1, Shanshan Cui, Yulong Chen
1Henan University of Chinese Medicine, Zhengzhou 450046, Henan, China. Corresponding author: Chen Yulong,
Objective:
As one of the top three causes of death in the world, chronic obstructive pulmonary disease (COPD)is a serious hazard to human health. Macrophages play an important role in COPD, and their efferocytosis function is essential for ending chronic inflammation of COPD. Efferocytosis damage of alveolar macrophages (AM) in patients with COPD causes the rising of bacterial infection and airway bacterial colonization risk in lungs, which is the main reason for the acute exacerbation and the rising of incidence rate and mortality rate in COPD. In recent years, the regulation of macrophage efferocytosis function in COPD has becoming a research hotspot. Progress on the role of macrophage efferocytosis function on COPD, and the breakthrough points of improving AM efferocytosis dysfunction by traditional Chinese medicine is reviewed, so as to provide new ideas for the prevention and treatment of COPD.
Insights
Chronic obstructive pulmonary disease (COPD) involves impaired macrophage efferocytosis, increasing infection risk. Traditional Chinese medicine shows promise in restoring this crucial immune function for COPD treatment.
Area of Science:
- Immunology
- Pulmonology
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading global cause of death.
- Macrophages, particularly alveolar macrophages (AMs), are critical in regulating inflammation in COPD.
- Impaired efferocytosis by AMs in COPD patients elevates risks of bacterial infection and airway colonization, driving exacerbations and mortality.
Purpose of the Study:
- To review the role of macrophage efferocytosis in COPD pathogenesis.
- To explore advancements in improving AM efferocytosis dysfunction.
- To highlight the potential of traditional Chinese medicine (TCM) in treating COPD by enhancing efferocytosis.
Main Methods:
- Literature review focusing on macrophage efferocytosis in COPD.
- Analysis of studies investigating mechanisms of efferocytosis dysfunction.
- Examination of research on TCM interventions for COPD and macrophage function.
Main Results:
- Efferocytosis is vital for resolving inflammation in COPD.
- Dysfunctional efferocytosis in COPD exacerbates disease progression and increases mortality.
- TCM presents potential therapeutic strategies for restoring AM efferocytosis.
Conclusions:
- Restoring macrophage efferocytosis is a key therapeutic target for COPD.
- TCM may offer novel approaches to manage COPD by improving AM efferocytosis.
- Further research into TCM mechanisms could lead to new COPD treatments.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

